A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

Sadick Research Group, New York

Mount Sinai School of Medicine, New York

Northeast Clinical Research Center, Allentown

Paddington Testing Company, Philadelphia

Radiant Research, Philadelphia

Wake Forest University School of Medicine, Winston-Salem

Atlanta Dermatology, Vein & Research Center, LLC, Alpharetta

North Florida Dermatology Associates, PA, Jacksonville

Comprehensive Research Institute, Tampa

ICSL-Clinical Studies, Sarasota

Dermatology Consultants, PC, Nashville

Harmony Clinical Research, Inc., Johnson City

University Dermatology Consultants, Inc., Cincinnatti

The South Bend Clinic, South Bend

Research Solutions, LLC, Evansville

Washington University School of Medicine, St Louis

Bressinck-Parker-Dinehart-Sangster Dermatology, PA, Little Rock

Breco Research, Ltd., Houston

Dermatology Clinical Research Center of San Antonio, San Antonio

Colorado Medical Research Center, Inc., Denver

Cherry Creek Dermatology, Denver

MDS Pharma Services (US) Inc., Phoenix

Dermatology Specialists, Inc., Vista

nTouch Research Corporation, San Diego

Associates in Research, Inc., Fresno

Solano Clinical Research, Vallejo

Oregon Medical Research Center, PC, Portland

The Savin Center, PC, New Haven

Northwestern University Medical School, Chicago

Massachusetts General Hospital, Boston

FutureCare Studies, Springfield

University of Medicine & Dentistry of New Jersey Robert Wood Johnson Medical School and Clinical Research Center, New Brunswick

Probe Inc., Riverside Park

Associates in Dermatology Research, Rutherford

Clinicalm Partners-LLC, Johnston

Veteran's Administration Medical Center, Nashville

The Dermatology Centre, Calgary

NewLab Clinical Research, St. John's

Queen Elizabeth II Health Sciences Center, Halifax

Probity Medical Research, Waterloo

Probity Medical Research, Windsor

Innovaderm Research Inc., Montreal

International Dermatology Research, Montreal